EARNEST Partners
CAPS

EARNEST Partners’s CAPSTONE THERAPEUTICS CORP COM STK (DE) CAPS Stock Holding History

EARNEST Partners’s Portfolio CAPS Stock Details CAPS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-11,100
Closed -$3K – 403
2014
Q2 		$3K Hold
11,100
– – ﹤0.01% 403
2014
Q1 		$3K Sell
11,100
-4,900
-31% -$1.32K ﹤0.01% 403
2013
Q4 		$4K Buy
+16,000
New +$4K ﹤0.01% 411

Other funds holding CAPS

MWP
MYCIO Wealth Partners Philadelphia, Pennsylvania $502M AUM 11.65% 1-Year Est. Return

EARNEST Partners's CAPS Position: Q3 2014 in Review

EARNEST Partners sold out of CAPSTONE THERAPEUTICS CORP COM STK (DE) (CAPS) in Q3 2014, closing a stake of 11,100 shares — an estimated $3K sold.

EARNEST Partners first reported a position in CAPS in Q4 2013 and held it in 3 quarters. The position peaked at $4K in Q4 2013. 1 fund tracked by Wall St. Rank holds CAPS as of Q3 2014.

  • EARNEST Partners reported no remaining CAPSTONE THERAPEUTICS CORP COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • EARNEST Partners sold 11,100 CAPSTONE THERAPEUTICS CORP COM STK (DE) shares in Q3 2014, an estimated $3K.
  • EARNEST Partners first reported a position in CAPSTONE THERAPEUTICS CORP COM STK (DE) in Q4 2013 and held it in 3 quarters.
  • EARNEST Partners's CAPSTONE THERAPEUTICS CORP COM STK (DE) position peaked at $4K in Q4 2013.
  • 1 fund tracked by Wall St. Rank held CAPSTONE THERAPEUTICS CORP COM STK (DE) as of Q3 2014.

Based on EARNEST Partners's 13F filing for Q3 2014, filed 14 Nov 2014.